Physician profile
Mehran Massumi
NPI 1942521711
$114,146.48
in general payments reported to CMS, 2019-2025
39 companies · $40K in 2025
The $40K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $2,586 · 2021: $4,584 · 2022: $7,494 · 2023: $20K · 2024: $27K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $16K · Travel and Lodging: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,031.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,300.00 |
| Food and Beverage | $15,748.31 |
| Travel and Lodging | $13,438.23 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $58,676.88 | 2019-2025 | Perclose Proglide, Absolute Pro, Supera |
| Boston Scientific Corporation | $16,034.30 | 2019-2025 | Ekosonic, Angiojet Ultra 5000a, General - Vascular Access |
| Bard Peripheral Vascular, INC. | $10,992.04 | 2019-2025 | Lutonix Drug Coated Balloon, Crosser Iq, Rotarexs 6 F X 135 Cm |
| Cagent Vascular INC | $7,092.24 | 2023-2025 | Serrantor |
| Medtronic, INC. | $3,464.20 | 2021-2025 | Venaseal, Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $2,911.12 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Inari Medical, INC. | $2,821.06 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $2,396.35 | 2019-2025 | |
| Penumbra, INC. | $1,942.42 | 2020-2024 | Indigo System |
| Cardiovascular Systems INC. | $1,535.82 | 2019-2022 | |
| Medtronic Vascular, INC. | $1,517.84 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $823.21 | 2022-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Cardioform Septal Occluder |
| Endologix LLC | $474.13 | 2025 | Endocross Device, Torus Stent Graft System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $435.30 | 2020-2024 | Lifevest |
| Teleflex LLC | $412.30 | 2021-2025 | Guideliner, Manta |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endotronix, INC. | $336.88 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Angiodynamics, INC. | $260.84 | 2022 | |
| Surmodics, INC. | $229.86 | 2023 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Actelion Pharmaceuticals US, INC. | $227.58 | 2020-2025 | Uptravi, Opsumit |
| Amgen INC. | $200.61 | 2019-2024 | Repatha |
| Astellas Pharma US INC | $194.79 | 2019-2021 | |
| Pfizer INC. | $184.56 | 2019-2024 | |
| Cook Medical LLC | $153.61 | 2025 | Zilver Ptx |
| Janssen Pharmaceuticals, INC | $142.74 | 2019-2021 | |
| Avinger INC. | $125.69 | 2020-2022 | |
| Shockwave Medical, INC | $100.35 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Saranas, INC. | $88.24 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $74.41 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $42.05 | 2022 | |
| Bridgebio Pharma, INC. | $35.42 | 2025 | Attruby |
| Cardiva Medical, INC. | $29.13 | 2022 | |
| Cvrx, INC. | $28.38 | 2025 | Barostim Neo System |
| Cardinal Health 200 LLC | $27.80 | 2021 | |
| Terumo Medical Corporation | $27.09 | 2024 | Metacross Otw, Tr Band, Angio-Seal |
| Bayer Healthcare Pharmaceuticals INC. | $26.88 | 2022 | |
| Impulse Dynamics (USA) INC. | $24.89 | 2023 | Optimizer |
| Portola Pharmaceuticals, LLC | $20.35 | 2019 | |
| Contego Medical, INC | $18.50 | 2024 | |
| Chiesi USA, INC. | $16.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$165.96 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehran Massumi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.